Rapid loss of blood-brain barrier P-glycoprotein activity through transporter internalization demonstrated using a novel in situ proteolysis protection assay.
Brian T Hawkins, Robert R Rigor, David S Miller
文献索引:J. Cereb. Blood Flow Metab. 30(9) , 1593-7, (2010)
全文:HTML全文
摘要
Blood-brain barrier (BBB) P-glycoprotein activity is rapidly reduced by vascular endothelial growth factor (VEGF) acting via Src and by tumor necrosis factor-alpha acting via protein kinase C (PKC)beta1. To probe underlying mechanism(s), we developed an in vivo, immunoblot-based proteinase K (PK) protection assay to assess the changes in the P-glycoprotein content of the BBB's luminal membrane. Infusion of PK into the brain vasculature selectively cleaved luminal membrane P-glycoprotein, leaving intracellular proteins intact. Intracerebroventricular injection of VEGF partially protected P-glycoprotein from proteolytic cleavage, consistent with transporter internalization. Activation of PKCbeta1 did not protect P-glycoprotein. Thus, VEGF and PKCbeta1 reduce P-glycoprotein activity by distinct mechanisms.
相关化合物
相关文献:
2001-02-01
[Carcinogenesis 22(2) , 221-31, (2001)]
2000-03-01
[Am. J. Physiol. Endocrinol. Metab. 278(3) , E553-62, (2000)]
1981-01-01
[Acta Pharmacol. Toxicol. (Copenh.) 48(1) , 47-52, (1981)]
1998-12-18
[J. Biol. Chem. 273(51) , 34639-45, (1998)]
1997-05-16
[Int. J. Cancer 71(4) , 691-7, (1997)]